AGLAIA ONCOLOGY FUNDS
Aglaia Oncology Funds is a financial service company that provides investment funds in the research of anti-cancer drugs.
AGLAIA ONCOLOGY FUNDS
Social Links:
Industry:
Biotechnology Financial Services Funding Platform Oncology
Founded:
2004-01-01
Address:
Bilthoven, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.aglaia-oncology.com
Total Employee:
1+
Status:
Active
Contact:
+31-30-229-6090
Email Addresses:
[email protected]
Technology used in webpage:
ReCAPTCHA ReCAPTCHA V2 Dutch Server Location
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
CDR-Life AG
CDR-Life AG is a biotech company that develops innovative therapeutic antibody fragments with a focus on immuno-oncology.
FMO
FMO is a financial investment firm that specializes in financing businesses and projects.
Maven Capital Partners
Maven Capital Partners is a private equity firm that provides a range of funding options to SMEs and investment opportunities.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
UCEA
UCEA is a single family office that offers investment opportunities across the sports, healthcare, financial inclusion, and energy sectors.
Current Employees Featured
Founder
Official Site Inspections
http://www.aglaia-oncology.com Semrush global rank: 16.08 M Semrush visits lastest month: 1
- Host name: vps11.websteen.nl
- IP address: 178.22.56.75
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Aglaia Oncology Funds"
Aglaia Oncology Funds - Crunchbase Company Profile & Funding
Aglaia Oncology Funds is a financial service company that provides investment funds in the research of anti-cancer drugs. Search Crunchbase. Start Free Trial . Chrome Extension. ...See details»
Ernst Geutjes | Aglaia Oncology Funds
He continued his career as business developer at the research- and technology organization TNO, where he had a role in spinning-out biotech companies. Ernst supports Aglaia in the analysis of investment proposals and offers strategic …See details»
Aglaia Oncology Funds - LinkedIn
Aglaia is an investment fund fully focused on the fight against cancer and the development of improved anti-cancer drugs in particular. Aglaia has a proven ability to select and mature early …See details»
Aglaia Oncology Funds investment portfolio | PitchBook
Jun 23, 2011 Aglaia Oncology Funds's latest investment was on 09-Feb-2021 in InteRNA Technologies, a company within the Drug Discovery industry. Data Transparency. Meet our …See details»
Aglaia Oncology Fund II: Performance - PitchBook
Dec 31, 2014 Aglaia Oncology Fund II is a 2014 vintage early stage venture capital fund managed by Aglaia Oncology Funds. The fund is located in Bilthoven, Netherlands. The fund …See details»
Aglaia Oncology Funds and Sinzer - Grant Thornton …
Dec 19, 2019 Aglaia offers investors an opportunity to combine an attractive financial return with a meaningful impact on healthcare and society. For more information about Aglaia, please visit: www.aglaia-oncology.com. About …See details»
Aglaia Oncology Funds - VentureRadar
"Aglaia Oncology Funds specializes in investing in early-stage oncology drug development companies. With decades of experience, Aglaia identifies and nurtures breakthrough cancer …See details»
Aglaia Oncology Funds - Contacts, Employees, Board Members
Aglaia Oncology Funds is a financial service company that provides investment funds in the research of anti-cancer drugs. ... Solutions. Products. Resources. Pricing. Resources. Log In. …See details»
Founder and Director @ Aglaia Oncology Funds - Crunchbase
Primary Organization . Aglaia Oncology Funds . Location Ranstad, Vastra Gotaland, Sweden; Regions European Union (EU), Nordic ... Mark Krul is the Founder and Director of Aglaia …See details»
Aglaia Oncology Funds - venturecapitalarchive.com
Oct 11, 2024 Aglaia Oncology Funds is an institutional investor specializing in oncology drug development companies. Established in 2004, Aglaia has built a strong reputation for its ability …See details»
Aglaia Oncology Fund III: Performance - PitchBook
Aglaia Oncology Fund III General Information Description. Aglaia Oncology Fund III is an early-stage venture capital managed by Aglaia Oncology Funds. The fund is located in Bilthoven, …See details»
Archive | Aglaia Oncology Funds
Sep 7, 2022 ISA Pharmaceuticals' Chief Scientific Officer Prof. Dr. Melief Awarded Fellowship at the Society for Immunotherapy of Cancer. July 15, 2022. Recognition of commendable, …See details»
Aglaia BioMedical Ventures - Company Profile & Staff Directory
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of …See details»
Aglaia BioMedical Ventures - Crunchbase
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities. ... Aglaia's focus on oncology is considered to be a …See details»
ESG - Aglaia Oncology Funds
Any such risks identified are considered by Aglaia when making investment decisions. Moreover, Aglaia in connection with certain AIF’s has created – in cooperation with Sinzer (a Grant …See details»
Stepping to the exit - PubMed
Sep 1, 2021 1 Aglaia Oncology Funds, Bilthoven, the Netherlands. 2 Aglaia Oncology Funds, Bilthoven, the Netherlands. [email protected]. PMID: 34462590 DOI: 10.1038/s41587 …See details»
News - Aglaia Oncology Funds
Aug 31, 2023 This abstract describes results of a randomized trial in advanced head and neck cancer with its lead therapeutic vaccine ISA101...See details»
Publication in Nature Biotechnology - Aglaia Oncology Funds
Stepping to the Exit - Publication in Nature Biotechnology. August 27, 2021. On August, 27 th 2021 an article has been published in Nature Biotechnology by Aglaia that aims to provide …See details»